COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,741 Articles (22,502 medRxiv, 8,239 bioRxiv)

Most recent first Previous |  Page 3016: Articles 30151-30160  | Next

Indications for healthcare surge capacity in European countries facing an exponential increase in COVID19 cases
Verelst, F., Kuylen, E. J., Beutels, P.
10.1101/2020.03.14.20035980 — Posted: 2020-03-17
International expansion of a novel SARS-CoV-2 mutant
Wang, M., Li, M., Ren, R., Brave, A., Werf, S. v. d., Chen, E.-Q., Zong, Z., Li, W., Ying, B.
10.1101/2020.03.15.20035204 — Posted: 2020-03-17 Discussion: Onsite
Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients
Pan, Y., Li, X., Yang, G., Fan, J., Tang, Y., Zhao, J., Long, X., Guo, S., Zhao, Z., Liu, Y., Hu, H., Xue, H., Li, Y.
10.1101/2020.03.13.20035428 — Posted: 2020-03-17
A high efficient hospital emergency responsive mode is the key of successful treatment of 100 COVID-19 patients in Zhuhai
Huang, J., Li, Z., Qu, X., Zheng, X., Tu, C., Chen, M., Tan, C., Liu, J., Shan, H.
10.1101/2020.03.15.20034629 — Posted: 2020-03-17
The effects of border control and quarantine measures on global spread of COVID-19
Hossain, M. P., Junus, A., Zhu, X., Jia, P., Wen, T.-H., Pfeiffer, D., Yuan, H.-Y.
10.1101/2020.03.13.20035261 — Posted: 2020-03-17
Covid-19 pandemic: on a simple way to visualize the epidemic states and trajectories of some European countries, and to assess the effect of delays in official response
Kevorkian, A., Grenet, T., Gallee, H.
10.1101/2020.03.14.20035964 — Posted: 2020-03-17 Discussion: Onsite
Modelling the epidemic 2019-nCoV event in Italy: a preliminary note
Traini, M. C., Caponi, C., De Socio, G. V.
10.1101/2020.03.14.20034884 — Posted: 2020-03-17
Impacts of social and economic factors on the transmission of coronavirus disease (COVID-19) in China
Qiu, Y., Chen, X., Shi, W.
10.1101/2020.03.13.20035238 — Posted: 2020-03-17 Discussion: Onsite
A Cybernetics-based Dynamic Infection Model for Analyzing SARS-COV-2 Infection Stability and Predicting Uncontrollable Risks
Xiao, W., Liu, Q., Huan, J., Sun, P., Wang, L., Zang, C., Zhu, S., Gao, L.
10.1101/2020.03.13.20034082 — Posted: 2020-03-17
Wuhan and Hubei COVID-19 mortality analysis reveals the critical role of timely supply of medical resources
Zhang, Z., Yao, W., Wang, Y., Long, C., FU, X.
10.1101/2020.03.13.20035410 — Posted: 2020-03-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).